AU-15330, CAS [[2380274-50-8]]

Produktübersicht

• Artikelname: AU-15330, CAS [[2380274-50-8]]
• Artikelnummer: MCE-HY-145388
• Hersteller Artikelnummer: HY-145388
• Alternativnummer: MCE-HY-145388-100MG,MCE-HY-145388-10MG,MCE-HY-145388-25MG,MCE-HY-145388-50MG,MCE-HY-145388-1MG,MCE-HY-145388-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

AU-15330 is a proteolysis-targeting chimera (PROTAC) degrader of the SWI/SNF ATPase subunits, SMARCA2 and SMARCA4. AU-15330 induces potent inhibition of tumour growth in xenograft models of prostate cancer and synergizes with the AR antagonist enzalutamide. AU-15330 induces disease remission in castration-resistant prostate cancer (CRPC) models without toxicity[1].

Produkteigenschaften

• Molekulargewicht: 755.93
• Reinheit: 99.89
• CAS Nummer: [2380274-50-8]
• Formel: C39H49N9O5S
• Target-Kategorie: PROTACs,SWI/SNF Complex

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound